Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Epilepsy and Seizures: Overview

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

Antiepileptic Drugs: Potassium Channel Activators

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Acute Abortive Therapies for Seizure Clusters in Long-Term Care.

Journal of the American Medical Directors Association·2023

Same author

Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial.

Epilepsia·2022

Same author

Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18-59 years) adults.

Epilepsy research·2020

Same author

Safety, tolerability, and pharmacokinetics of weight-based IV loading dose of lacosamide in the ICU.

Epilepsy & behavior : E&B·2020

Same author

Current and evolving treatment strategies for the Alzheimer disease continuum.

The American journal of managed care·2020

Same author

Lamotrigine pharmacokinetics following oral and stable-labeled intravenous administration in young and elderly adult epilepsy patients: Effect of age.

Epilepsia·2018

Same journal

Digging Deeper Into the Patient-Driven Payment Model.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018

Same journal

Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018

Same journal

Statins: The Burglar of Memory?

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018

Same journal

Identifying Cognitive Impairment in an Older Adult Using Two Different Screening Tools.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018

Same journal

Management of Primary Sjögren's Syndrome.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018

Same journal

Increased Use of Medical Marijuana: Skepticism vs. Evidence.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Managing epilepsy: issues in the elderly.

Richard A Marasco¹, R Eugene Ramsay

¹Pharmaceutical Care and Management Services, Valdosta, GA, USA. rmarasco@seniorpharm.com

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists

|June 27, 2009

Summary

This summary is machine-generated.

Managing epilepsy in older adults requires careful consideration of health conditions and multiple medications. Pharmacist involvement is crucial for effective care planning and reducing adverse drug events in elderly epilepsy patients.

More Related Videos

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

Related Experiment Videos

Last Updated: Jun 22, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

Area of Science:

Geriatric Medicine
Neurology
Clinical Pharmacy

Background:

Epilepsy treatment in the elderly presents unique challenges.
Comorbidities and polypharmacy complicate management.
Antiepileptic drug (AED) therapy requires careful monitoring.

Purpose of the Study:

To identify factors influencing epilepsy treatment in the elderly.
To outline strategies for AED discontinuation in seizure-free patients.
To develop a comprehensive epilepsy care plan for residents.

Main Methods:

Content derived from a live symposium.
Based on current clinical practice.
Informed by relevant research.

Main Results:

Elderly epilepsy management is complex due to comorbidities and polypharmacy.
Minimizing drug interactions and monitoring efficacy/toxicity are essential.
Pharmacist consultation is vital for optimizing treatment.

Conclusions:

Consultant pharmacists are integral to epilepsy care in nursing facilities.
Integration of pharmacists in care plan development is recommended.
Proactive management can improve outcomes for elderly epilepsy patients.